Authors: GAYLOR DW AXELRAD JA BROWN RP CAVAGNARO JA CYR WH HULEBAK KL LORENTZEN RJ MILLER MA MULLIGAN LT SCHWETZ BA

Citation: Dw. Gaylor et al., HEALTH RISK ASSESSMENT PRACTICES IN THE US FOOD-AND-DRUG-ADMINISTRATION, Regulatory toxicology and pharmacology, 26(3), 1997, pp. 307-321

Authors: FORAN JA ALLABEN WT ASHBY J BASS R WHARF C BUCHER JR BURNAM W BUS JS BUTTERWORTH BE CARAKOSTAS M EMERSON J CARDONA RA COHEN SM DEGEORGE J FENNERCRISP P GAYLOR D GEE JF GOODMAN JI GRANT DL HATTAN DG HAYASHI Y HENDERSON RF HERRMAN JL KOETER HBWM LEBOEUF RA LORENTZEN RJ MCCONNELL EE MITSUMORI K OLIN SS PARKER JC RENWICK A STEVENS JT SWENBERG JA TAYLOR AS VANGEMERT M VU V WALKER R WATSON M YIELDING KL

Citation: Ja. Foran et al., PRINCIPLES FOR THE SELECTION OF DOSES IN CHRONIC RODENT BIOASSAYS, Environmental health perspectives, 105(1), 1997, pp. 18-20

Authors: LORENTZEN RJ

Citation: Rj. Lorentzen, IMPACT OF THE DELANEY-CLAUSE AT THE FDA, Experimental and toxicologic pathology, 48(2-3), 1996, pp. 198-198

Authors: BURIN GJ CLAYSON DB COHEN SM DESESSO JM ELLWEIN LB FISHBEIN L FREDERICK C GIBB H GORELICK NJ HARD GC HILL RN KING C LORENTZEN RJ OYASU R RICE JM SANDUSKY C WANG CY WARD JM

Citation: Gj. Burin et al., URINARY-BLADDER CARCINOGENESIS - IMPLICATIONS FOR RISK ASSESSMENT, Food and chemical toxicology, 33(9), 1995, pp. 797-802

Authors: GAYLOR DW KODELL RL CHEN JJ SPRINGER JA LORENTZEN RJ SCHEUPLEIN RJ

Citation: Dw. Gaylor et al., POINT ESTIMATES OF CANCER RISK AT LOW-DOSES, Risk analysis, 14(5), 1994, pp. 843-850